NEW YORK (GenomeWeb) – Transplant Genomics today announced a deal to exclusively license patent rights from The Scripps Research Institute and Northwestern University.

The Brookline, Mass.-based company will have access to intellectual property related to kidney and liver transplant diagnostics, such as immune status monitoring and optimization, and it intends to use the licensed technology develop and commercialize tests based on genomic biomarkers of transplant graft status. The tests would be used as part of a surveillance program to detect early signs of graft injury.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.